Gregoire Leclair, Ph.D. - Publications

Affiliations: 
2003 Université de Montréal, Montréal, Canada 
Area:
Pharmacy

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lessard JJ, Caron E, Schérer H, Forest JM, Leclair G. Compatibility of Y-Site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hospital Pharmacy. 55: 332-337. PMID 32999503 DOI: 10.1177/0018578719844168  0.331
2019 Puscas I, Bernard-Patrzynski F, Jutras M, Lécuyer MA, Bourbonnière L, Prat A, Leclair G, Roullin VG. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. Pharmaceutics. 11. PMID 31717321 DOI: 10.3390/Pharmaceutics11110587  0.327
2019 Vallée M, Barthélémy I, Friciu M, Pelletier É, Forest J, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration: Hospital Pharmacy. 1857871988891. DOI: 10.1177/0018578719888913  0.317
2018 Tehrani SF, Bernard-Patrzynski F, Puscas I, Leclair G, Hildgen P, Roullin VG. Length of surface PEG modulates nanocarrier transcytosis across brain vascular endothelial cells. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30582996 DOI: 10.1016/J.Nano.2018.11.016  0.604
2018 Melkoumov A, St-Jean I, Banquy X, Leclair G, Leblond-Chain J. GM1-Binding Conjugates to Improve Intestinal Permeability. Molecular Pharmaceutics. PMID 30422668 DOI: 10.1021/Acs.Molpharmaceut.8B00776  0.304
2018 Elkin I, Maris T, Melkoumov A, Hildgen P, Banquy X, Leclair G, Barrett C. Crystal structure of 2-oxopyrrolidin-3-yl 4-(2-phenyl-diazen-1-yl)benzoate. Acta Crystallographica. Section E, Crystallographic Communications. 74: 458-460. PMID 29765745 DOI: 10.1107/S205698901800333X  0.674
2017 Friciu M, Roullin VG, Leclair G. Stability of gabapentin in extemporaneously compounded oral suspensions. Plos One. 12: e0175208. PMID 28414771 DOI: 10.1371/Journal.Pone.0175208  0.329
2016 Friciu M, Zaraa S, Roullin VG, Leclair G. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions. Plos One. 11: e0164577. PMID 27727306 DOI: 10.1371/Journal.Pone.0164577  0.331
2016 Nabais T, Zaraa S, Leclair G. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile. Drug Development and Industrial Pharmacy. 1-7. PMID 27109692 DOI: 10.1080/03639045.2016.1181080  0.382
2016 Friciu M, Savji T, Zaraa S, Leclair G. Evaluation of stability of melatonin in extemporaneously compounded oral suspensions Journal of Pharmacy Practice and Research. 46: 28-33. DOI: 10.1002/Jppr.1171  0.351
2015 Sullivan T, Forest JM, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration. Hospital Pharmacy. 50: 214-20. PMID 26405311 DOI: 10.1310/Hpj5003-214  0.302
2014 Nabais T, Leclair G. High-amylose sodium carboxymethyl starch matrices: development and characterization of tramadol hydrochloride sustained-release tablets for oral administration. Isrn Pharmaceutics. 2014: 391523. PMID 25006518 DOI: 10.1155/2014/391523  0.401
2013 Hossain MA, Boily S, Beauregard N, Forest JM, Leclair G. Stability of betaine capsules. Isrn Pharmaceutics. 2013: 458625. PMID 23862077 DOI: 10.1155/2013/458625  0.331
2013 Le Dévédec F, Strandman S, Hildgen P, Leclair G, Zhu XX. PEGylated bile acids for use in drug delivery systems: enhanced solubility and bioavailability of itraconazole. Molecular Pharmaceutics. 10: 3057-66. PMID 23837910 DOI: 10.1021/Mp400117M  0.649
2013 Melkoumov A, Goupil M, Louhichi F, Raymond M, de Repentigny L, Leclair G. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. The Journal of Antimicrobial Chemotherapy. 68: 2099-105. PMID 23620465 DOI: 10.1093/Jac/Dkt137  0.301
2011 Melkoumov A, Soukrati A, Elkin I, Forest JM, Hildgen P, Leclair G. Quality evaluation of extemporaneous delayed-release liquid formulations of lansoprazole. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 68: 2069-74. PMID 22011986 DOI: 10.2146/Ajhp100634  0.686
2011 Sylvestre JP, Tang MC, Furtos A, Leclair G, Meunier M, Leroux JC. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. Journal of Controlled Release : Official Journal of the Controlled Release Society. 149: 273-80. PMID 21047539 DOI: 10.1016/J.Jconrel.2010.10.034  0.329
2009 Hammady T, Rabanel JM, Dhanikula RS, Leclair G, Hildgen P. Functionalized nanospheres loaded with anti-angiogenic drugs: cellular uptake and angiosuppressive efficacy. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 72: 418-27. PMID 19462478 DOI: 10.1016/J.Ejpb.2009.01.007  0.668
2008 Banquy X, Leclair G, Rabanel JM, Argaw A, Bouchard JF, Hildgen P, Giasson S. Selectins ligand decorated drug carriers for activated endothelial cell targeting. Bioconjugate Chemistry. 19: 2030-9. PMID 18803413 DOI: 10.1021/Bc800257M  0.629
2007 Bertrand N, Leclair G, Hildgen P. Modeling drug release from bioerodible microspheres using a cellular automaton. International Journal of Pharmaceutics. 343: 196-207. PMID 17616285 DOI: 10.1016/J.Ijpharm.2007.05.050  0.645
2005 Nadeau V, Leclair G, Sant S, Rabanel JM, Quesnel R, Hildgen P. Synthesis of new versatile functionalized polyesters for biomedical applications Polymer. 46: 11263-11272. DOI: 10.1016/J.Polymer.2005.09.079  0.608
2002 Ruel-Gariépy E, Leclair G, Hildgen P, Gupta A, Leroux JC. Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 373-83. PMID 12175750 DOI: 10.1016/S0168-3659(02)00146-3  0.637
Show low-probability matches.